The metabolic syndrome and risk of incident colorectal cancer - PubMed (original) (raw)
Multicenter Study
. 2006 Jul 1;107(1):28-36.
doi: 10.1002/cncr.21950.
Affiliations
- PMID: 16721800
- DOI: 10.1002/cncr.21950
Free article
Multicenter Study
The metabolic syndrome and risk of incident colorectal cancer
Rehana L Ahmed et al. Cancer. 2006.
Free article
Abstract
Background: The authors tested the hypothesis that the metabolic syndrome (> or =3 of the following components: high blood pressure, increased waist circumference, hypertriglyceridemia, low levels of high-density lipoprotein cholesterol, or diabetes/hyperglycemia) is a risk factor for colorectal cancer.
Methods: Data from the Atherosclerosis Risk in Communities (ARIC) multicenter prospective cohort study were used. Metabolic syndrome components and other risk factors were collected during 1987 to 1989 from the 14,109 men and women in these analyses. One hundred ninety-four incident colorectal cancers were identified through the Year 2000. Multivariate Cox proportional hazards regression analyses were used to examine associations.
Results: Baseline metabolic syndrome (> or =3 components vs. 0 components) had a positive association with age-adjusted and gender-adjusted colorectal cancer incidence (relative risk [RR], 1.49; 95% confidence interval [95%CI], 1.0-2.4); this association was attenuated after multivariate adjustment (RR, 1.39; 95%CI, 0.9-2.2). There was a dose-response association between colorectal cancer incidence and the number of metabolic syndrome components present at baseline (P for trend = .006) after multivariate adjustment. Analysis of gender revealed that the multivariate-adjusted association of metabolic syndrome with colorectal cancer was stronger in men (RR, 1.78; 95%CI, 1.0-3.6) and weaker in women (RR, 1.16; 95%CI, 0.6-2.2).
Conclusions: In this population-based cohort, metabolic syndrome was a risk factor for incident colorectal cancer in men but not women. Evidence is growing that the metabolic syndrome may be a marker for a physiologic milieu of growth that encourages tumor initiation, promotion, and/or progression.
Copyright 2006 American Cancer Society.
Similar articles
- Gender difference in metabolic syndrome and incident colorectal adenoma: A prospective observational study (KCIS No.42).
Ku MS, Chiu SY, Chien KL, Lee YC, Chen SL, Chen CD. Ku MS, et al. Medicine (Baltimore). 2021 Jun 4;100(22):e26121. doi: 10.1097/MD.0000000000026121. Medicine (Baltimore). 2021. PMID: 34087861 Free PMC article. - Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis.
Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Rafaniello C, Panagiotakos DB, Giugliano D. Esposito K, et al. Endocrine. 2013 Dec;44(3):634-47. doi: 10.1007/s12020-013-9939-5. Epub 2013 Apr 2. Endocrine. 2013. PMID: 23546613 Review. - Metabolic syndrome, its components, and gastrointestinal cancer risk: a meta-analysis of 31 prospective cohorts and Mendelian randomization study.
Zhan ZQ, Chen YZ, Huang ZM, Luo YH, Zeng JJ, Wang Y, Tan J, Chen YX, Fang JY. Zhan ZQ, et al. J Gastroenterol Hepatol. 2024 Apr;39(4):630-641. doi: 10.1111/jgh.16477. Epub 2024 Jan 17. J Gastroenterol Hepatol. 2024. PMID: 38230882 Review. - Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT Study, Norway.
Snekvik I, Nilsen TIL, Romundstad PR, Saunes M. Snekvik I, et al. Br J Dermatol. 2019 Jan;180(1):94-99. doi: 10.1111/bjd.16885. Epub 2018 Sep 16. Br J Dermatol. 2019. PMID: 29904911 - Association Between Metabolic Syndrome and the Risk of Colorectal Cancer Diagnosed Before Age 50 Years According to Tumor Location.
Jin EH, Han K, Lee DH, Shin CM, Lim JH, Choi YJ, Yoon K. Jin EH, et al. Gastroenterology. 2022 Sep;163(3):637-648.e2. doi: 10.1053/j.gastro.2022.05.032. Epub 2022 May 25. Gastroenterology. 2022. PMID: 35643169
Cited by
- Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: From the oral cavity to rectum.
Kuo YC, Yu LY, Wang HY, Chen MJ, Wu MS, Liu CJ, Lin YC, Shih SC, Hu KC. Kuo YC, et al. World J Gastrointest Oncol. 2022 Jan 15;14(1):55-74. doi: 10.4251/wjgo.v14.i1.55. World J Gastrointest Oncol. 2022. PMID: 35116103 Free PMC article. Review. - Differential predictive factors for cardiovascular events in patients with or without cancer history.
Sueta D, Tabata N, Ikeda S, Saito Y, Ozaki K, Sakata K, Matsumura T, Yamamoto-Ibusuki M, Murakami Y, Jodai T, Fukushima S, Yoshida N, Kamba T, Araki E, Iwase H, Fujii K, Ihn H, Kobayashi Y, Minamino T, Yamagishi M, Maemura K, Baba H, Matsui K, Tsujita K. Sueta D, et al. Medicine (Baltimore). 2019 Nov;98(44):e17602. doi: 10.1097/MD.0000000000017602. Medicine (Baltimore). 2019. PMID: 31689764 Free PMC article. - Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease.
Touzin NT, Bush KN, Williams CD, Harrison SA. Touzin NT, et al. Therap Adv Gastroenterol. 2011 May;4(3):169-76. doi: 10.1177/1756283X11402118. Therap Adv Gastroenterol. 2011. PMID: 21694801 Free PMC article. - Specific features of colorectal cancer in patients with metabolic syndrome: a matched case-control analysis of 772 patients.
Zarzavadjian Le Bian A, Denet C, Tabchouri N, Donatelli G, Wind P, Louvet C, Bennamoun M, Christidis C, Perniceni T, Fuks D, Gayet B. Zarzavadjian Le Bian A, et al. Langenbecks Arch Surg. 2018 Jun;403(4):443-450. doi: 10.1007/s00423-018-1677-y. Epub 2018 Apr 27. Langenbecks Arch Surg. 2018. PMID: 29704123
Publication types
MeSH terms
Grants and funding
- N01-HC 55015/HC/NHLBI NIH HHS/United States
- N01-HC 55016/HC/NHLBI NIH HHS/United States
- N01-HC 55018/HC/NHLBI NIH HHS/United States
- N01-HC 55019/HC/NHLBI NIH HHS/United States
- N01-HC 55020/HC/NHLBI NIH HHS/United States
- N01-HC 55021/HC/NHLBI NIH HHS/United States
- N01-HC 55022/HC/NHLBI NIH HHS/United States
- R03-CA65473/CA/NCI NIH HHS/United States
- T32 CA09607-15/CA/NCI NIH HHS/United States
- T32 GM08244-15/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases